Effect of rosiglitazone on the expression of cardiac adiponectin receptors and NADPH oxidase in type 2 diabetic rats

European Journal of Pharmacology

Volumn 685, Issue 1-3, 2012, Pages 116-125

  Guo, Zhixin ^a   Qin, Zhihong ^a   Zhang, Rong ^a   Li, Jiawei ^a   Yin, Yan ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin receptor; Cardiomyopathy; NADPH oxidase; Rosiglitazone; Type 2 diabetic

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; AMP KINASE ALPHA; CONNECTIVE TISSUE GROWTH FACTOR; GLUCOSE TRANSPORTER 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; P22PHOX PROTEIN; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLUORESCENCE ANALYSIS; HEART FUNCTION; HEART WEIGHT; IMMUNOHISTOCHEMISTRY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84861347397     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.010     Document Type: Article

References (47)

1. Abel, E.D., Kaulbach, H.C., Tian, R., Hopkins, J.C., Duffy, J., Doestschman, T., Minnemann, T., Boers, M.E., Hadro, E., Oberste-Berghaus, C., Quist, W., Lowell, B.B., Ingwall, J.S., Kahn, B.B., 1999. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest. 104, 1703-1714.
2. Ago, T., Kuroda, J., Pain, J., Fu, C., Li, H., Sadoshima, J., 2010. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ. Res. 106, 1253-1264.
3. American Diabetes Association, 1998. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21, 296-309.
4. Arozal, W., Watanabe, K., Veeraveedu, P.T., Ma, M., Thandavarayan, R.A., Suzuki, K., Tachikawa, H., Kodama, M., Aizawa, Y., 2009. Effects of angiotensin receptor blocker on oxidative stress and cardio-renal function in streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 32, 1411-1416.
5. Baraka, A., AbdelGawad, H., 2010. Targeting apoptosis in the heart of streptozotocininduced diabetic rats. J. Cardiovasc. Pharmacol. Ther. 15, 175-181.
6. Bilan, V.P., Salah, E.M., Bastacky, S., Jones, H.B., Mayers, R.M., Zinker, B., Poucher, S.M., Tofovic, S.P., 2011. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats. J. Endocrinol. 210, 293-308.
7. Boyle, A.J., Yeghiazarians, Y., Shih, H., Hwang, J., Ye, J., Sievers, R., Zheng,D., Palasubramaniam, J., Palasubramaniam, D., Karschimkus, C., Whitbourn, R., Jenkins, A., Wilson, A.M., 2011. Myocardial production and release of MCP-1 AND SDF-1 followingmyocardial infarction: differences between mice and man. J. Transl. Med. 12, 150.
8. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
9. Cheng, G., Cao, Z., Xu, X., van Meir, E.G., Lambeth, J.D., 2001. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269, 131-140.
10. Chinetti, G., Zawadski, C., Fruchart, J.C., Staels, B., 2004. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem. Biophys. Res. Commun. 314, 151-158.
11. Ding, G., Qin, Q., He, N., Francis-David, S.C., Hou, J., Liu, J., Ricks, E., Yang, Q., 2007. Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J. Mol. Cell. Cardiol. 43, 73-84.
12. Dong, F., Ren, J., 2009. Adiponectin improve cardiomyocyte contractile function in db/ db diabetic obese mice. Obesity (Silver Spring) 17, 262-268.
13. Drimal, J., Knezl, V., Navarova, J., Nedelcevova, J., Paulovicova, E., Sotnikova, R., Snirc, V., Drimal, D., 2008. Role of inflammatory cytokines and chemoattractants in the rat model of atreptozotocin-induced diabetic heart failure. Endocr. Regul. 42, 129-135.
14. Garvey, W.T., Hardin, D., Juhaszova, M., Dominguez, J.H., 1993. Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy. Am. J. Physiol. 264, H837-H844.
15. Giugliano, D., Ceriello, A., Paolisso, G., 1995. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44, 363-368.
16. Griendling, K.K., Sorescu, D., Ushio-Fukai, M., 2000. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501.
17. Guo, Z., Xia, Z., Jiang, J., McNeill, J.H., 2007. Down-regulation of NADPH oxidase, antioxidant enzymes and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetylcysteine. Am. J. Physiol. Heart Circ. Physiol. 292, H1728-H1736.
18. Guo, Z., Zheng, C., Qin, Z., Wei, P., 2011. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats. J. Pharm. Pharmacol. 63, 87-94.
19. Hattori, Y., Akimoto, K., Gross, S.S., Hattori, S., Kasai, K., 2005. Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats. Diabetologia 48, 1066-1074.
20. Hwang, J., Kleinhenz, D.J., Rupnow, H.L., Campbell, A.G., Thulé, P.M., Sutliff, R.L., Hart, C.M., 2007. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice. Vascul. Pharmacol. 46, 456-462.
21. Ihm, S.H., Chang, K., Kim, H.Y., Baek, S.H., Youn, H.J., Seung, K.B., Kim, J.H., 2010. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and connective tissue growth factor. Basic Res. Cardiol. 105, 399-407.
22. Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., Ogata, H., Kubota, N., Takamoto, I., Hayashi, Y.K., Yamauchi, N., Waki, H., Fukayama, M., Nishino, I., Tokuyama, K., Ueki, K., Oike, Y., Ishii, S., Hirose, K., Shimizu, T., Touhara, K., Kadowaki, T., 2010. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464, 1313-1319.
23. Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M.D., Sadoshima, J., 2010. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. U. S. A. 107, 15565-15570.
24. Lee, T.I., Kao, Y.H., Chen, Y.C., Pan, N.H., Lin, Y.K., Chen, Y.J., 2011. Cardiac peroxisomeproliferator- activated receptor expression in hypertension co-existing with diabetes. Clin. Sci. (Lond) 121, 305-312.
25. Liao, Y., Takashima, S., Maeda, N., Ouchi, N., Komamura, K., Shimomura, I., Hori, M., Matsuzawa, Y., Funahashi, T., Kitakaza, M., 2005. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc. Res. 67, 705-713.
26. Lim, C.S., Vaziri, N.D., 2004. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int. 65, 1802-1809.
27. Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using realtime PCR and the 2(Delta Delta C(T)) method. Methods 25, 402-408.
28. Lopaschuk, G.D., 2002. Metabolic abnormalities in the diabetic heart. Heart Fail. Rev. 7, 149-159.
29. Maalouf, R.M., Eid, A.A., Gorin, Y.C., Block, K., Escobar, G.P., Bailey, S., Abboud, H.E., 2012. Nox4-Derived Reactive Oxygen species mediate cardiomyocyte injury in early type 1 diabetes. Am. J. Physiol. Cell Physiol. 302, C597-C604.
30. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., Matsubara, K., 1996. cDNA cloning and expression of a novel adipose specific collage-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286-289.
31. Maeda, N., Takahashi,M., Funahashi, T., Kihara, S., Nishizawa,H., Kishida, K., Nagaretani, H., Matsuda,M., Komuro, R., Ouchi, N., Kuriyama, H., Hotta, K., Nakamura, T., Shimomura, I., Matsuzawa, Y., 2001. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50, 2094-2099.
32. Mueckler, M., 1990. Family of glucose transporter genes. Implications for glucose homeostasis and diabetes. Diabetes 39, 6-11.
33. Piñeiro, R., Iglesias, M.J., Gallego, R., Raghay, K., Eiras, S., Rubio, J., Diéguez, C., Gualillo, O., González-Juanatey, J.K., Lago, F., 2005. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 579, 5163-5169.
34. Rosen, P., Du, X., Tschope, D., 1998. Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol? Mol. Cell. Biochem. 188, 103-111.
35. Russell, R.R., Bergeron, R., Shulman, G.I., Young, L.H., 1999. Translocation of myocardial GLUT4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol. Heart Circ. Physiol. 277, H643-H649.
36. Rutter, G.A., Da Silva Xavier, G., Leclerc, I., 2003. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homeostasis. Biochem. J. 375, 1-16.
37. Sharma, S., Adrogue, J.V., Golfman, L., Uray, I., Lemn, J., Youker, K., Noon, G.P., Frazier, O.H., Taegtmeyer, H., 2004. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 18, 1692-1700.
38. Shibata, R., Ouchi, N., Ito, M., Kihara, S., Shiojima, I., Pimentel, D.R., Kumada, M., Sato, K., Schiekofer, S., Ohashi, K., Funahashi, T., Colucci, W.S., Walsh, K., 2004. Adiponectinmediated modulation of hypertrophic signals in the heart. Nat. Med. 10, 1384-1389.
39. Shioi, T., Matsumori, A., Kihara, Y., Inoko, M., Ono, K., Iwanaga, Y., Yamada, T., Iwasaki, A., Matsushima, K., Sasayama, S., 1997. Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ. Res. 81, 664-671.
40. Sun, X., He, J., Mao, C., Han, R., Wang, Z., Liu, Y., Chen, Y., 2008. Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element. FEBS Lett. 582, 3401-3407.
41. Thandavarayan, R.A., Watanabe, K., Ma, M., Gurusamy, N., Veeraveedu, P.T., Konishi, T., Zhang, S., Muslin, A.J., Kodama, M., Aizawa, Y., 2009. Dominant-negative p38alpha mitogen-activated protein kinase prevents cardiac apoptosis and remodeling after streptozotocin-induced diabetes mellitus. Am. J. Physiol. Heart Circ. Physiol. 297, H911-H919.
42. Trujillo, M.E., Scherer, P.E., 2005. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J. Intern. Med. 257, 167-175.
43. Tsao, T.S., Stenbit, A.E., Factor, S.M., Chen, W., Rossetti, L., Charron, M.J., 1999. Prevention of insulin resistance and diabetes in mince heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes 48, 775-782.
44. Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., Kamon, J., Kobayashi, M., Suzuki, R., Hara, K., Kubota, N., Terauchi, Y., Froguel, P., Nakae, J., Kasuga, M., Accili, D., Tobe, K., Ueki, K., Nagai, R., Kadowaki, T., 2004. Insulin / Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 279, 30817-30822.
45. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., Eto, K., Akanuma, Y., Froguel, P., Foufelle, F., Ferre, P., Carling, D., Kimura, S., Nagain, R., Kahn, B.B., Kadowaki, T., 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295.
46. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N.H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R., Kadowaki, T., 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769.
47. Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., Ito, Y., Kamon, J., Tsuchida, A., Kumagai, K., Kozono, H., Hada, Y., Ogata, H., Tokuyama, K., Tsunoda, M., Ide, T., Murakami, K., Awazawa, M., Takamoto, I., Froguel, P., Hara, K., Tobe, K., Nagai, R., Ueki, K., Kadowaki, T., 2007. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat. Med. 13, 332-339.